ESPOSITO, Silvano
 Distribuzione geografica
Continente #
NA - Nord America 7.109
EU - Europa 2.319
AS - Asia 1.685
SA - Sud America 76
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 2
Totale 11.213
Nazione #
US - Stati Uniti d'America 7.076
UA - Ucraina 643
CN - Cina 557
IT - Italia 535
SG - Singapore 517
DE - Germania 301
RU - Federazione Russa 256
VN - Vietnam 256
FI - Finlandia 191
IE - Irlanda 177
KR - Corea 150
TR - Turchia 150
SE - Svezia 77
BR - Brasile 62
FR - Francia 43
NL - Olanda 33
CA - Canada 26
GB - Regno Unito 24
IN - India 17
HK - Hong Kong 13
AR - Argentina 11
EU - Europa 10
CZ - Repubblica Ceca 8
IQ - Iraq 6
AT - Austria 4
IL - Israele 4
BD - Bangladesh 3
BG - Bulgaria 3
GR - Grecia 3
HR - Croazia 3
ZA - Sudafrica 3
BE - Belgio 2
CU - Cuba 2
EC - Ecuador 2
ES - Italia 2
IR - Iran 2
MA - Marocco 2
MK - Macedonia 2
MX - Messico 2
RO - Romania 2
RS - Serbia 2
UZ - Uzbekistan 2
AU - Australia 1
AZ - Azerbaigian 1
CG - Congo 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
IS - Islanda 1
JP - Giappone 1
KE - Kenya 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.213
Città #
Ann Arbor 1.981
Wilmington 879
Jacksonville 797
Chandler 691
Princeton 574
Woodbridge 368
Houston 294
Dong Ket 256
Ashburn 179
Dublin 176
Nanjing 166
Andover 144
Izmir 144
Singapore 139
Pellezzano 117
Boardman 108
Munich 92
Salerno 63
Mestre 62
Düsseldorf 61
Fairfield 56
Beijing 53
Changsha 53
Shenyang 47
Moscow 44
Hebei 43
Nanchang 43
Helsinki 42
Jiaxing 41
Redwood City 26
Dallas 24
Norwalk 24
Tianjin 24
Ottawa 18
Cambridge 15
Los Angeles 13
San Diego 12
Guangzhou 11
Napoli 11
Rome 11
Seattle 11
Hong Kong 10
Jyväskylä 10
Pune 10
Dearborn 9
Falls Church 9
Washington 9
Jinan 8
Meppel 8
Milan 8
Redmond 8
Brno 7
Naples 7
Paterno 7
Dronten 6
Phoenix 5
São Paulo 5
Canepina 4
Council Bluffs 4
Edinburgh 4
London 4
Munro 4
Venezia 4
Amsterdam 3
Baghdad 3
Bareggio 3
Bologna 3
Federal 3
Goiânia 3
Hangzhou 3
Indiana 3
Lanzhou 3
Monza 3
Muizenberg 3
New York 3
Palermo 3
Shanghai 3
Shenzhen 3
Sofia 3
Southwark 3
Stockholm 3
Vico Equense 3
Vienna 3
Zagreb 3
Aachen 2
Albignasego 2
Alessandria 2
Andra 2
Belgrade 2
Brussels 2
Cairate 2
Collegeville 2
Contagem 2
Curitiba 2
Cusano Milanino 2
Dolo 2
Genoa 2
Gloucester 2
Havana 2
Jerusalem 2
Totale 8.158
Nome #
Sphingomonas paucimobilis osteomyelitis in an immunocompetent patient. 216
Trattamento delle riacutizzazioni infettive di otiti croniche sostenute da stafilococco: studio aperto non comparativo con teicoplanina. 205
Surveillance of post-operative infections and management of antibiotic surgical prophylaxis in an Italian region 170
Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia 169
Outpatient parenteral antibiotic therapy for bone and joint infections: an italian multicenter study 159
Clinical efficacy and tolerability of levofloxacin in patients with liver disease: a prospective, non comparative, observational study 145
Bacterial Epidemiology and Antimicrobial Resistance in the Surgery Wards of a Large Teaching Hospital in Southern Italy 130
Antibiotic prophylaxis in hernia repair and breast surgery: a prospective randomized study comparing piperacillin/tazobactam versus placebo 124
Outpatient parenteral antibiotic therapy in the elderly: an Italian observational multicenter study 123
[Outpatient Parenteral Antibiotic Therapy (OPAT): the Italian registry] 123
Antibiotic resistance in long-term care facilities 123
A pilot study on prevention of catheter-related urinary tract infections with fluoroquinolones 123
Adjuvant treatment of diabetic foot 111
null 111
Amoxicillina/acido clavulanico nel trattamento delle otiti medie. 109
[Outpatient parenteral antibiotic therapy (OPAT) of diabetic foot infections with piperacillin/tazobactam] 109
Foot infections in diabetes (DFIs) in the out-patient setting: an Italian multicentre observational survey 109
[Skin and soft tissue infections: classification and epidemiology] 105
In vitro activity of six beta-lactam antibiotics against non-beta-lactamase producing and producing enterobacteria and antibiotic resistance transfer. 104
Attività batteriostatica e battericida di Levofloxacina e Ciprofloxacina verso uropatogeni determinata mediante MIC, MBC, Time-kill curves e analisi dell’indice di batteriocidia. 101
Transient bacteraemia due to Chryseobacterium indologenes in an immunocompetent patient: a case report and literature review 100
Factors related to outcome of early and delayed prosthetic joint infections. 97
Prosthetic joint infections: microbiology, diagnosis, management and prevention 96
Multicentre survey of post-surgical infections in Campania (Italy) 96
Le infezioni del piede diabetico: aspetti microbiologici 96
[Catheter-associated urinary tract infections: epidemiology and prevention] 95
In vitro activity of tigecycline: MICs, MBCs, time-kill curves and post-antibiotic effect 94
Diagnostic and therapeutic appropriateness in bone and joint infections: results of a national survey 91
Antibiotic prophylaxis in catheter-associated urinary infections. 90
A European survey of antibiotic management of methicillin-resistantStaphylococcus aureusinfection: current clinical opinion and practice 89
Aggiornamenti in tema di infezioni del piede diabetico 89
Epidemiology and antibiotic resistance in a large Italian teaching hospital 89
Bacterial meningitis complicating the course of liver cirrhosis 89
Antimicrobial treatment for Intensive Care Unit (ICU) infections including the role of the infectious disease specialist 88
Ciprofloxacin in the treatment of severe bacterial infections. 88
Lymph node fine needle cytology in infectious diseases: A clinical perspective 87
Italian Guidelines for the Diagnosis and Infectious Disease Management of Osteomyelitis and Prosthetic Joint Infections in Adults 86
International OPAT Registry. Outpatint parenteral antibiotic therapy (OPAT) in different countries: a comparison. 85
[Skin and soft tissue infections: current therapeutic options] 85
Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens 85
Epidemiology and microbiology of skin and soft tissue infections 85
Listeria monocytogenes meningitis in the elderly: Epidemiological, clinical and therapeutic findings 85
[Early and timely therapy: when to interrupt antibiotic therapy in nosocomial acquired pneumonia?] 84
Deep tissue biopsy vs. superficial swab culture, including microbial loading determination, in the microbiological assessment of Skin and Soft Tissue Infections (SSTIs) 84
Treatment options for skin and soft tissue infections caused by meticillin-resistant Staphylococcus aureus:oralvs.parenteral; home vs. hospital 83
Considerations on antibiotic therapy duration in community- and hospital-acquired bacterial infections 81
Antibiotici ed Immunità 81
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections. 81
Antibiotic dose adjustment in patients with advanced liver disease. 80
Infezioni da Staphylococcus aureus meticillino-resistente: Ruolo dell’associazione daptomicina/β-lattamici 80
Hot topics in the diagnosis and management of skin and soft-tissue infections. 80
New insights into classification, epidemiology and microbiology of SSTIs, including diabetic foot infections 80
Antibiotic prophylaxis in surgery: an observational prospective study conducted in a large teaching hospital in Naples. 79
Antimicrobial therapy duration: a major matter in the management of severe infections. 79
Intestinal helminths in immigrants in Naples (Italy): a comparison between two different diagnostic techniques 79
New insights in biological targets and therapeutic management of infectious diseases. 78
Central venous catheter-related biofilm infections: An up-to-date focus on meticillin-resistant Staphylococcus aureus 78
Sensibilità in vitro dei batteri Gram positivi di maggiore rilevanza clinica, Studio multicentrico. 77
Analysis of current guidelines for the treatment of skin and soft tissue infections 76
Irrigation and debridement 76
Management of severe bacterial infections and role of the infectious disease specialist: results of an interview-based survey 76
[In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens] 75
Managing skin and soft-tissue infection and nosocomial pneumonia caused by MRSA: A 2014 follow-up survey 75
Changing modalities of outpatient parenteral antimicrobial therapy use over time in Italy: A comparison of two time periods 75
Attività antibatterica del cefuroxime in colture miste in un modello in vitro di farmacodinamica. 74
Newinsights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis,treatment and resistance. 73
Adverse effects of intravenous antibiotic therapy. 73
Early discharge of infectious disease patients: an opportunity or extra cost for the Italian Healthcare System? 72
Prosthetic joints: shining lights on challenging blind spots. 72
Attualità in tema di antibiotico-profilassi in chirurgia. 71
Valutazione clinica della Sultamicillina in confronto alla amoxicillina nel trattamento delle infezioni urinarie, respiratorie ed ORL 70
Management of severe bacterial infections 70
Streptococcus gordonii extensive multiple subcutanoeusabscesses 69
Epidemiologia dei fenomeni di resistenza nell’ambito di Streptococcus pneumonaie e nuovi fluorochinoloni ad attività antipneumococcica. 69
BRAF ( V600E ) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma. 69
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic hematopoietic stem cell transplantation 67
Le infezioni delle vie urinarie: problemi di eziopatogenesi e terapia. 67
Low dose ciprofloxacin in the treatment of bacterial pharyngo-tonsillitis 67
Management of serious bacterial infections: general considerations 67
Visceral leishamiosis in immunocompromised host: an update and literature review. 67
[Update on diabetic foot infections.] 66
Changes in intestinal microflora following levofloxacin administration in laboratory animals 65
Low-dose valgancyclovir as cytomegalovirus reactivation prophylaxis in allogeneic haematopoietic stem cell transplantation. 65
Su un caso di infezione da Salmonella typhi multiresistente. 64
Trattamenti adiuvanti del piede diabetico 64
Epidemiologia ed eziologia nelle infezioni respiratorie comunitarie. 64
Ofloxacina per via topica versus Ceftazidime per via intramuscolare nel trattamento delle infezioni dell'orecchio medio. 64
Percutaneous liver biopsy and transient bacteremia 63
Lesioni infette del piede diabetico 62
Il trattamento delle infezioni batteriche in comunità: il modello italiano come modello internazionale? 62
Le infezioni delle alte e basse vie respiratorie. Aspetti di microbiologia clinica e di farmcodinamica. 62
Le infezioni del piede diabetico: aspetti microbiologici. Diabetic foot infections: microbiological aspects 62
La complessità della terapia antibiotica nel piede diabetico infetto 62
Comment on: outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service. 61
L'impiego della Ciprofloxacina orale nelle infezioni batteriche delle alte vie respiratorie. 61
Raccolta di esperienze cliniche nell’uso di Ceftriaxone in profilassi chirurgica: introduzione. 61
Changes in intestinal microflora induced by ciprofloxacin and treatment of portal systemic encephalopaty 61
Diabetic foot: definitions. 61
[Current guidelines for the treatment of intra-abdominal infections] 61
Il cipropfloxacin nel trattamento delle infezioni gastrointestinali. 60
Totale 8.759
Categoria #
all - tutte 37.422
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.422


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020193 0 0 0 0 0 0 0 0 0 0 173 20
2020/20211.191 13 133 137 2 175 39 164 10 132 0 112 274
2021/2022978 4 2 0 1 28 20 6 35 150 143 138 451
2022/20231.623 170 74 17 189 269 322 7 203 251 5 89 27
2023/2024552 65 94 38 23 41 61 9 42 6 52 21 100
2024/20251.232 78 34 25 75 53 204 276 211 234 32 10 0
Totale 11.531